what is the dose for microdosing glp 1 GLP-1 Explained Microdosing GLP-1s: Does It Work?

Inzucchi SE, Zinman B, Fitchett D, Wanner C, Ferrannini E, Schumacher M, et al

At the pathogenic level, PsO and PsA share core inflammatory mechanisms driven by dysregulation of the IL17/IL23 and Tumour Necrosis Factor (TNF)- cytokine axes (14), contributing to keratinocyte hyperproliferation, synovial inflammation, and enthesial disease (1518)

Restraints - High Cost of Therapy The high cost of therapy is a significant restraint for the GLP-1 receptor agonist market, limiting patient access and long-term adoption

Triplet combo: Semaglutide + high-dose trevogrumab + garetosmab (antiactivin A) Endpoints : At Week 26, evaluated percent change in body weight, lean mass, and fat mass via DXA (dual-energy X-ray absorptiometry)

Semaglutide also helps to reduce blood pressure